Cano Health, Inc. (NYSE: CANO) Stock Competitors & Peer Comparison
See CANO's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CANO and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CANO | $2.30 | -2.13% | 12.4M | -0.01 | -$228.47 | N/A |
| HCA | $382.19 | +1.51% | 84.8B | 13.20 | $28.96 | +0.78% |
| THC | $233.20 | +17.17% | 20.1B | 13.53 | $17.24 | N/A |
| DVA | $235.44 | +0.50% | 15.1B | 20.06 | $11.73 | N/A |
| SOLV | $78.01 | +1.00% | 13.5B | 12.50 | $6.24 | N/A |
| FMS | $24.59 | +0.61% | 13.2B | 9.76 | $2.52 | +3.52% |
| EHC | $112.89 | +1.65% | 11.2B | 19.83 | $5.69 | +0.67% |
| ENSG | $172.99 | +3.27% | 10.1B | 25.07 | $6.90 | +0.15% |
| UHS | $155.75 | +2.96% | 9.8B | 6.91 | $22.54 | +0.51% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CANO vs HCA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while HCA trades at $382.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas HCA's P/E ratio is 13.20. In terms of profitability, CANO's ROE is -1.49%, compared to HCA's ROE of -1.54%. Regarding short-term risk, CANO is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CANO vs THC Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, THC has a market cap of 20.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while THC trades at $233.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas THC's P/E ratio is 13.53. In terms of profitability, CANO's ROE is -1.49%, compared to THC's ROE of +0.38%. Regarding short-term risk, CANO is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for CANO.Check THC's competition here
DaVita Inc. (NYSE: DVA)
CANO vs DVA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, DVA has a market cap of 15.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while DVA trades at $235.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas DVA's P/E ratio is 20.06. In terms of profitability, CANO's ROE is -1.49%, compared to DVA's ROE of -1.33%. Regarding short-term risk, CANO is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
CANO vs SOLV Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SOLV trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SOLV's P/E ratio is 12.50. In terms of profitability, CANO's ROE is -1.49%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, CANO is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CANO vs FMS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, FMS has a market cap of 13.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while FMS trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas FMS's P/E ratio is 9.76. In terms of profitability, CANO's ROE is -1.49%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CANO is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
CANO vs EHC Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, EHC has a market cap of 11.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while EHC trades at $112.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas EHC's P/E ratio is 19.83. In terms of profitability, CANO's ROE is -1.49%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CANO is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for CANO.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CANO vs ENSG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ENSG trades at $172.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ENSG's P/E ratio is 25.07. In terms of profitability, CANO's ROE is -1.49%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CANO is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
CANO vs UHS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, UHS has a market cap of 9.8B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while UHS trades at $155.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas UHS's P/E ratio is 6.91. In terms of profitability, CANO's ROE is -1.49%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CANO is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
CANO vs OSH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas OSH's P/E ratio is -17.65. In terms of profitability, CANO's ROE is -1.49%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CANO is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
CANO vs PACS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while PACS trades at $46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas PACS's P/E ratio is 39.80. In terms of profitability, CANO's ROE is -1.49%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CANO is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
CANO vs CHE Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CHE trades at $511.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CHE's P/E ratio is 23.66. In terms of profitability, CANO's ROE is -1.49%, compared to CHE's ROE of +0.25%. Regarding short-term risk, CANO is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CANO vs LHCG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CANO's ROE is -1.49%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CANO is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CANO vs LFST Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while LFST trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas LFST's P/E ratio is 173.65. In terms of profitability, CANO's ROE is -1.49%, compared to LFST's ROE of +0.02%. Regarding short-term risk, CANO is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for CANO.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
CANO vs CON Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CON has a market cap of 4B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CON's P/E ratio is 21.95. In terms of profitability, CANO's ROE is -1.49%, compared to CON's ROE of +0.46%. Regarding short-term risk, CANO is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CANO vs BKD Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, BKD has a market cap of 3.6B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while BKD trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas BKD's P/E ratio is -26.11. In terms of profitability, CANO's ROE is -1.49%, compared to BKD's ROE of +401.19%. Regarding short-term risk, CANO is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for CANO.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
CANO vs NHC Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NHC trades at $225.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NHC's P/E ratio is 32.32. In terms of profitability, CANO's ROE is -1.49%, compared to NHC's ROE of +0.12%. Regarding short-term risk, CANO is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for CANO.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CANO vs OPCH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while OPCH trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas OPCH's P/E ratio is 12.59. In terms of profitability, CANO's ROE is -1.49%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, CANO is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
CANO vs AMED Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AMED's P/E ratio is 39.30. In terms of profitability, CANO's ROE is -1.49%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CANO is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CANO vs ACHC Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ACHC has a market cap of 3.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ACHC trades at $34.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ACHC's P/E ratio is 17.34. In terms of profitability, CANO's ROE is -1.49%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, CANO is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CANO vs MD Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while MD trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas MD's P/E ratio is 12.27. In terms of profitability, CANO's ROE is -1.49%, compared to MD's ROE of +0.20%. Regarding short-term risk, CANO is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for CANO.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CANO vs ADUS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ADUS trades at $114.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ADUS's P/E ratio is 17.79. In terms of profitability, CANO's ROE is -1.49%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, CANO is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ADUS's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CANO vs AVAH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AVAH trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AVAH's P/E ratio is 13.90. In terms of profitability, CANO's ROE is -1.49%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, CANO is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AVAH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CANO vs SGRY Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SGRY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SGRY's P/E ratio is 40.33. In terms of profitability, CANO's ROE is -1.49%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, CANO is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SGRY's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CANO vs SEM Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SEM's P/E ratio is 15.43. In terms of profitability, CANO's ROE is -1.49%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CANO is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CANO vs ASTH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ASTH trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ASTH's P/E ratio is 27.24. In terms of profitability, CANO's ROE is -1.49%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, CANO is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CANO vs AMEH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CANO's ROE is -1.49%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, CANO is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
CANO vs AGL Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AGL trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AGL's P/E ratio is -9.57. In terms of profitability, CANO's ROE is -1.49%, compared to AGL's ROE of -1.46%. Regarding short-term risk, CANO is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CANO vs INNV Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while INNV trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas INNV's P/E ratio is -128.44. In terms of profitability, CANO's ROE is -1.49%, compared to INNV's ROE of -0.09%. Regarding short-term risk, CANO is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for CANO.Check INNV's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CANO vs HCSG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while HCSG trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas HCSG's P/E ratio is 18.19. In terms of profitability, CANO's ROE is -1.49%, compared to HCSG's ROE of +0.23%. Regarding short-term risk, CANO is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
CANO vs ARDT Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ARDT trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ARDT's P/E ratio is 6.47. In terms of profitability, CANO's ROE is -1.49%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, CANO is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ARDT's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CANO vs PNTG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while PNTG trades at $41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas PNTG's P/E ratio is 33.46. In terms of profitability, CANO's ROE is -1.49%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, CANO is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CANO vs AMN Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AMN trades at $32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AMN's P/E ratio is 10.93. In terms of profitability, CANO's ROE is -1.49%, compared to AMN's ROE of -0.05%. Regarding short-term risk, CANO is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CANO vs BKDT Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas BKDT's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, CANO is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for CANO.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CANO vs USPH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while USPH trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas USPH's P/E ratio is 28.74. In terms of profitability, CANO's ROE is -1.49%, compared to USPH's ROE of +0.00%. Regarding short-term risk, CANO is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check USPH's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
CANO vs CMPS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CMPS trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CMPS's P/E ratio is -5.49. In terms of profitability, CANO's ROE is -1.49%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, CANO is more volatile compared to CMPS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CMPS's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
CANO vs FSHCX Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, FSHCX has a market cap of 882M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while FSHCX trades at $120.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas FSHCX's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to FSHCX's ROE of N/A. Regarding short-term risk, CANO is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for CANO.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CANO vs TALKW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TALKW has a market cap of 874.4M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TALKW's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, CANO is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CANO.Check TALKW's competition here
Talkspace, Inc. (NASDAQ: TALK)
CANO vs TALK Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TALK's P/E ratio is 768.44. In terms of profitability, CANO's ROE is -1.49%, compared to TALK's ROE of +0.01%. Regarding short-term risk, CANO is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for CANO.Check TALK's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CANO vs NUTX Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NUTX has a market cap of 868.6M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NUTX trades at $145.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NUTX's P/E ratio is 11.27. In terms of profitability, CANO's ROE is -1.49%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, CANO is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for CANO.Check NUTX's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CANO vs SNDA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SNDA has a market cap of 833.8M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SNDA trades at $41.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SNDA's P/E ratio is -7.72. In terms of profitability, CANO's ROE is -1.49%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, CANO is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
CANO vs EHAB Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CANO's ROE is -1.49%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CANO is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for CANO.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
CANO vs GMRS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, GMRS has a market cap of 594M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while GMRS trades at $12.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas GMRS's P/E ratio is 5.76. In terms of profitability, CANO's ROE is -1.49%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, CANO is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CANO vs TOI Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TOI has a market cap of 497.9M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TOI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TOI's P/E ratio is -13.83. In terms of profitability, CANO's ROE is -1.49%, compared to TOI's ROE of +3.27%. Regarding short-term risk, CANO is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for CANO.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CANO vs VMD Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, VMD has a market cap of 451.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while VMD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas VMD's P/E ratio is 31.81. In terms of profitability, CANO's ROE is -1.49%, compared to VMD's ROE of +0.11%. Regarding short-term risk, CANO is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for CANO.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CANO vs MCTA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CANO's ROE is -1.49%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CANO is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CANO vs SRTA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SRTA has a market cap of 436.1M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SRTA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SRTA's P/E ratio is -35.46. In terms of profitability, CANO's ROE is -1.49%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, CANO is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CANO vs TOIIW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, CANO's ROE is -1.49%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, CANO is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for CANO.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
CANO vs CYH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CYH has a market cap of 384M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CYH trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CYH's P/E ratio is 3.73. In terms of profitability, CANO's ROE is -1.49%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CANO is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for CANO.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
CANO vs AUNA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AUNA has a market cap of 373.8M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AUNA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AUNA's P/E ratio is 4.55. In terms of profitability, CANO's ROE is -1.49%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, CANO is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CANO vs AIRS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AIRS has a market cap of 325.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AIRS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AIRS's P/E ratio is -153.67. In terms of profitability, CANO's ROE is -1.49%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, CANO is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
CANO vs CSU Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CSU's P/E ratio is 0.67. In terms of profitability, CANO's ROE is -1.49%, compared to CSU's ROE of -0.51%. Regarding short-term risk, CANO is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
CANO vs JYNT Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, JYNT has a market cap of 119M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while JYNT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas JYNT's P/E ratio is 83.50. In terms of profitability, CANO's ROE is -1.49%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, CANO is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for CANO.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
CANO vs BTMD Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, BTMD has a market cap of 100.6M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while BTMD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas BTMD's P/E ratio is 5.18. In terms of profitability, CANO's ROE is -1.49%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, CANO is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for CANO.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CANO vs FVE Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas FVE's P/E ratio is -5.64. In terms of profitability, CANO's ROE is -1.49%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CANO is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for CANO.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CANO vs KDLYW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, CANO is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for CANO.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
CANO vs DCGO Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, DCGO has a market cap of 58.9M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while DCGO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas DCGO's P/E ratio is -0.68. In terms of profitability, CANO's ROE is -1.49%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, CANO is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for CANO.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
CANO vs ALR Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ALR's P/E ratio is -1.11. In terms of profitability, CANO's ROE is -1.49%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CANO is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for CANO.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CANO vs PARK Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, PARK has a market cap of 36.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while PARK trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas PARK's P/E ratio is 25.36. In terms of profitability, CANO's ROE is -1.49%, compared to PARK's ROE of -0.24%. Regarding short-term risk, CANO is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for CANO.Check PARK's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CANO vs IMAC Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CANO's ROE is -1.49%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CANO is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for CANO.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CANO vs PIII Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, PIII has a market cap of 31.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while PIII trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas PIII's P/E ratio is -0.24. In terms of profitability, CANO's ROE is -1.49%, compared to PIII's ROE of +1.85%. Regarding short-term risk, CANO is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for CANO.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
CANO vs CCEL Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CCEL has a market cap of 28.1M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CCEL trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CCEL's P/E ratio is -10.55. In terms of profitability, CANO's ROE is -1.49%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, CANO is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
CANO vs CANO-WT Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, CANO is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for CANO.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CANO vs AIH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AIH's P/E ratio is -2.78. In terms of profitability, CANO's ROE is -1.49%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CANO is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for CANO.Check AIH's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CANO vs FPCG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CANO's ROE is -1.49%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CANO is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CANO vs FTRP Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CANO's ROE is -1.49%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CANO is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for CANO.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
CANO vs AMS Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AMS's P/E ratio is -6.47. In terms of profitability, CANO's ROE is -1.49%, compared to AMS's ROE of -0.06%. Regarding short-term risk, CANO is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CANO vs BMGL Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while BMGL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas BMGL's P/E ratio is -1.11. In terms of profitability, CANO's ROE is -1.49%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CANO is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for CANO.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
CANO vs XWEL Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, XWEL has a market cap of 6.4M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while XWEL trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas XWEL's P/E ratio is -0.32. In terms of profitability, CANO's ROE is -1.49%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, CANO is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for CANO.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
CANO vs MODV Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas MODV's P/E ratio is -0.06. In terms of profitability, CANO's ROE is -1.49%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CANO is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for CANO.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CANO vs GBNH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CANO's ROE is -1.49%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CANO is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for CANO.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CANO vs RHE Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas RHE's P/E ratio is -1.79. In terms of profitability, CANO's ROE is -1.49%, compared to RHE's ROE of -0.36%. Regarding short-term risk, CANO is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for CANO.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CANO vs RHE-PA Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CANO's ROE is -1.49%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, CANO is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for CANO.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CANO vs AIDX Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AIDX has a market cap of 2.8M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AIDX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AIDX's P/E ratio is -0.93. In terms of profitability, CANO's ROE is -1.49%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, CANO is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CANO vs IMACW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas IMACW's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CANO is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CANO.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
CANO vs NAKAW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, CANO's ROE is -1.49%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, CANO is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for CANO.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CANO vs CCM Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, CCM has a market cap of 626.1K. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while CCM trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas CCM's P/E ratio is -0.29. In terms of profitability, CANO's ROE is -1.49%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CANO is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for CANO.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CANO vs NIVF Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NIVF has a market cap of 212.3K. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NIVF's P/E ratio is 0.55. In terms of profitability, CANO's ROE is -1.49%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CANO is more volatile compared to NIVF. This indicates higher risk in terms of short-term price fluctuations for CANO.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CANO vs MNDR Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, MNDR has a market cap of 53.6K. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while MNDR trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas MNDR's P/E ratio is -0.05. In terms of profitability, CANO's ROE is -1.49%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CANO is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for CANO.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CANO vs NIVFW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CANO's ROE is -1.49%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CANO is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for CANO.Check NIVFW's competition here
DocGo Inc. (NASDAQ: DCGOW)
CANO vs DCGOW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, CANO is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for CANO.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CANO vs TLMDW Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CANO is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for CANO.Check TLMDW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CANO vs DVCR Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CANO's ROE is -1.49%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CANO is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for CANO.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CANO vs ATIP-WT Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CANO is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for CANO.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CANO vs TVTY Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CANO's ROE is -1.49%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CANO is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for CANO.Check TVTY's competition here
Hanger, Inc. (NYSE: HNGR)
CANO vs HNGR Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CANO's ROE is -1.49%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CANO is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for CANO.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
CANO vs NFH Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, NFH has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas NFH's P/E ratio is -19.75. In terms of profitability, CANO's ROE is -1.49%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CANO is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for CANO.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CANO vs SLHG Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CANO's ROE is -1.49%, compared to SLHG's ROE of N/A. Regarding short-term risk, CANO is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SLHG's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CANO vs KND Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, KND has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas KND's P/E ratio is -1.14. In terms of profitability, CANO's ROE is -1.49%, compared to KND's ROE of -0.53%. Regarding short-term risk, CANO is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for CANO.Check KND's competition here
Almost Family Inc. (NASDAQ: AFAM)
CANO vs AFAM Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas AFAM's P/E ratio is N/A. In terms of profitability, CANO's ROE is -1.49%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CANO is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for CANO.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CANO vs TLMD Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CANO's ROE is -1.49%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CANO is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for CANO.Check TLMD's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CANO vs SLHGP Comparison July 2026
Cano Health, Inc. (NYSE: CANO) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANO stands at 12.4M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CANO is priced at $2.30 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANO currently has a P/E ratio of -0.01, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CANO's ROE is -1.49%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CANO is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for CANO.Check SLHGP's competition here